HYAL decision highlights importance of relevant public in assessing registrability
The General Court confirmed that the relevant public, which consisted of professionals, would understand Fidia farmaceutici's mark HYAL as a direct reference to hyaluronic acid.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the WTR experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10